Current molecular classification is typically based on PAM50, which is a 50-gene expression signature that classifies BC in five molecular intrinsic subtypes: Luminal A, Luminal B, HER2-enriched, Basal-like, and Normal-like. This evidence concerns the gene ERBB2 and breast cancer.